Literature DB >> 21904639

Immunohistochemical profile of normal mesothelium and histiocytic/methothelial hyperplasia: a case report.

Tadashi Terada1.   

Abstract

Immunohistochemical profiles of normal mesothelium and histiocytic/mesothelial hyperplasia (HMH) are unknown. A 19-year-old man was treated by thoracoscopic resection of bullae of left lung. Histologically, there were cell proliferative foci composed of round cells without significant atypia (histiocyte, mesothelium and T-lymphocytes). The cell proliferative foci were patch-like, and no invasive features were seen. Because it is composed of histiocytes, mesothelium, and T-lymphocytes, the diagnosis was HMH. Immunohistochemically, cell components of HMH showed the following immunoreactions: calrenitin 3+, D2-40 3+, pancytokeratin AE1/3 3+, pancytokeratin CAM5.2 3+, cytokeratin (CK) 34βE12 1+, CK5/6 1+, CK7 1+, CK8 3+, CK 14 1+, CK18 2+, CK19 2+, p53 10%, Ki67 20%, CD68 3+, CD45 2+, CD45 RO 2+, vimentin 3+, Ber-EP4 -, CK20 -, EMA -, desmin -, CEA -, CA19-9 -, TTF-1 -, S100 protein -, αsmooth muscle actin -, CD34 -, CD20 -, chromogranin -, synaptophysin -, NSE -, CDX2 -, CD56 -, HER2 -, MUC1 -, MUC2 -, MUC5AC -, and MUC6 -. The normal mesothelium showed the following immunoprofile: calrenitin 3+, D2-40 3+, pancytokeratin AE1/3 3+, pancytokeratin CAM5.2 3+, CK34βE12 3+, CK5/6 2+, CK7 2+, CK8 3+, CK 14 -, CK18 3+, CK19 2+, vimentin 1+, p53 -, Ki67 1%, CD68 -, CD45 -, CD45 RO -, Ber-EP4 -, CK20 -, EMA -, desmin -, CEA -, CA19-9 -, TTF-1 -, S100 protein -, α-smooth muscle actin -, CD34 -, chromogranin -, synaptophysin -, NSE -, CDX2 -, CD56 -, HER2 -, MUC1 -, MUC2 -, MUC5AC -, and MUC6 -. These findings indicate that the immunoprolfile of mesothelium in HMH was immunohistochemically very similar to that of normal mesothelium except for CD68, p53 protein, Ki-67 labeling, CD45 and CD45 RO. These indicate that the HMH was reactive phenomenon and HMH is composed of hyperplastic mesothelium, histiocytes and T-lymphocytes. The immunoprofile of normal mesothelium provide basic knowledge of mesothelial pathology.

Entities:  

Keywords:  Mesothelium; histiocytic methothelial hyperplasia; immunohistochemical profile

Mesh:

Substances:

Year:  2011        PMID: 21904639      PMCID: PMC3160615     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  11 in total

1.  The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation.

Authors:  G N Soosay; M Griffiths; L Papadaki; L Happerfield; L Bobrow
Journal:  J Pathol       Date:  1991-04       Impact factor: 7.996

2.  Lesions described as nodular mesothelial hyperplasia are primarily composed of histiocytes.

Authors:  N G Ordóñez; J Y Ro; A G Ayala
Journal:  Am J Surg Pathol       Date:  1998-03       Impact factor: 6.394

3.  Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth.

Authors:  Tadashi Terada; Masaharu Kawaguchi; Kazuo Furukawa; Yasutomo Sekido; Yoshiyuki Osamura
Journal:  Pathol Int       Date:  2002-11       Impact factor: 2.534

4.  Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma.

Authors:  Yasufumi Kato; Koji Tsuta; Kunihiko Seki; Akiko Miyagi Maeshima; Shunichi Watanabe; Kenji Suzuki; Hisao Asamura; Ryosuke Tsuchiya; Yoshihiro Matsuno
Journal:  Mod Pathol       Date:  2006-12-22       Impact factor: 7.842

5.  Nodular mesothelial hyperplasia in hernia sacs: a benign reactive condition simulating a neoplastic process.

Authors:  J Rosai; L P Dehner
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

6.  Primary clear cell adenocarcinoma of the peritoneum.

Authors:  Tadashi Terada; Masaharu Kawaguchi
Journal:  Tohoku J Exp Med       Date:  2005-07       Impact factor: 1.848

7.  The diagnostic value of Ki-67 and repp86 in distinguishing between benign and malignant mesothelial proliferations.

Authors:  Zohreh Mohammad Taheri; Mehdi Mehrafza; Forozan Mohammadi; Maliheh Khoddami; Moslem Bahadori; Mohammad Reza Masjedi
Journal:  Arch Pathol Lab Med       Date:  2008-04       Impact factor: 5.534

8.  Cell proliferation rate and telomerase activity in the differential diagnosis between benign and malignant mesothelial proliferations.

Authors:  Caglar Cakir; Mine G Gulluoglu; Dilek Yilmazbayhan
Journal:  Pathology       Date:  2006-02       Impact factor: 5.306

9.  The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2.

Authors:  R L Attanoos; A Griffin; A R Gibbs
Journal:  Histopathology       Date:  2003-09       Impact factor: 5.087

10.  Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.

Authors:  Aliya N Husain; Thomas V Colby; Nelson G Ordóñez; Thomas Krausz; Alain Borczuk; Philip T Cagle; Lucian R Chirieac; Andrew Churg; Francoise Galateau-Salle; Allen R Gibbs; Allen M Gown; Samuel P Hammar; Leslie A Litzky; Victor L Roggli; William D Travis; Mark R Wick
Journal:  Arch Pathol Lab Med       Date:  2009-08       Impact factor: 5.534

View more
  8 in total

1.  Human interleukin-10 gene inhibits acute rejection by triggering apoptosis in allograft vascular transplantation.

Authors:  Haibo Liu; Shunzhang Yang; Xuejun Sun; Tianbao Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas.

Authors:  David Sanchez-Martin; Thomas S Uldrick; Hyeongil Kwak; Hidetaka Ohnuki; Mark N Polizzotto; Christina M Annunziata; Mark Raffeld; Kathleen M Wyvill; Karen Aleman; Victoria Wang; Vickie A Marshall; Denise Whitby; Robert Yarchoan; Giovanna Tosato
Journal:  J Natl Cancer Inst       Date:  2017-09-01       Impact factor: 13.506

3.  The fate of the fresh autologous pericardium after right ventricular outflow tract reconstruction.

Authors:  Hassan Tatari; Gholamreza Omrani; Maedeh Arabian; Kambiz Mozaffari; Yaser Toloueitabar; Sanaz Asadian; Nader Givtaj; Maziar Gholampour Dehaki; Amirhosein Jalali
Journal:  J Cardiovasc Thorac Res       Date:  2022-03-07

4.  Thyroid Solid Cell Nests: Usefulness of Cytokeratin 5/6? : Cytokeratin 5/6 in Thyroid Cell Nests.

Authors:  Adriana Handra-Luca
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

5.  Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases.

Authors:  Justyna Mikuła-Pietrasik; Paweł Uruski; Patrycja Sosińska; Konstantin Maksin; Hanna Piotrowska-Kempisty; Małgorzata Kucińska; Marek Murias; Sebastian Szubert; Aldona Woźniak; Dariusz Szpurek; Stefan Sajdak; Katarzyna Piwocka; Andrzej Tykarski; Krzysztof Książek
Journal:  Cell Death Dis       Date:  2016-12-29       Impact factor: 8.469

6.  Combination of inductive effect of lipopolysaccharide and in situ mechanical conditioning for forming an autologous vascular graft in vivo.

Authors:  Chao-Lin Chen; How-Ran Guo; Ying-Jan Wang; Hong-Tai Chang; Chui-Yi Pan; Ho-Yi Tuan-Mu; Hsiu-Chuan Lin; Chao-Yi Chen; Jin-Jia Hu
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

7.  Proliferative index using Ki-67 index in reactive mesothelial versus metastatic adenocarcinoma cells in serous fluid.

Authors:  Noushin Afshar Moghaddam; Alireza Rahmani; Diana Taheri; Mojtaba Mokhber Desfuli
Journal:  Adv Biomed Res       Date:  2012-07-06

8.  Embryonic mesothelial-derived hepatic lineage of quiescent and heterogenous scar-orchestrating cells defined but suppressed by WT1.

Authors:  Timothy James Kendall; Catherine Mary Duff; Luke Boulter; David H Wilson; Elisabeth Freyer; Stuart Aitken; Stuart John Forbes; John Peter Iredale; Nicholas Dixon Hastie
Journal:  Nat Commun       Date:  2019-10-15       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.